Biologics, biosilimars, and biobetters: different terms or different drugs?
Eye (Lond)
.
2019 Jul;33(7):1032-1034.
doi: 10.1038/s41433-019-0391-5.
Epub 2019 Mar 7.
Authors
Ashish Sharma
1
,
Nilesh Kumar
2
,
Baruch D Kuppermann
3
,
Francesco Bandello
4
,
Anat Loewenstein
5
Affiliations
1
Department of Vitreoretina, Lotus Eye Hospital and Institute, Coimbatore, TN, India. drashish79@hotmail.com.
2
Department of Vitreoretina, Lotus Eye Hospital and Institute, Coimbatore, TN, India.
3
Gavin Herbert Eye Institute, University of California, Irvine, Irvine, CA, USA.
4
Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milano, Italy.
5
Division of Ophthalmology, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
PMID:
30846867
PMCID:
PMC6707288
DOI:
10.1038/s41433-019-0391-5
No abstract available
Publication types
Review
MeSH terms
Biological Products / pharmacology*
Eye Diseases / drug therapy*
Humans
Ophthalmology / methods*
Substances
Biological Products